RETRACTED ARTICLE: MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro

Abstract

Zhou K, Fan Y, Wu P, et al. Onco Targets Ther. 2017;10:1625–1635.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.

We were notified of potential image manipulation in the published article. The issues relate to the alleged duplication of Panels C and G in Figure 6, Panels B and F in Figure 7 and Panels B and F in Figure 8. The authors responded to our queries but were unable to provide a satisfactory explanation for the alleged duplication or provide satisfactory raw data relating to the figures in question. The editor determined the findings of the study were no longer valid and requested for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords:

• invasive pituitary adenoma
• microRNA-145
• mTOR signaling pathway
• proliferation
• invasion
• AKT3

View retraction statement:

MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction]